Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick van Soolingen

Showing results (161-170 of 273) with videos related to

Pageof 28
Sort By:
Antimicrobial Agents and Chemotherapy|May 22, 2013
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomesMai N T Huyen, Frank G J Cobelens, Tran N Buu, et al.
Journal of Clinical Microbiology|March 7, 2006
Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year periodKathleen L Horan, Robert Freeman, Kris Weigel, et al.
Veterinary Immunology and Immunopathology|June 9, 2004
TB diagnosis in non-human primates: comparison of two interferon-gamma assays and the skin test for identification of Mycobacterium tuberculosis infectionRichard A W Vervenne, Stephen L Jones, Dick van Soolingen, et al.
BMC Infectious Diseases|February 5, 2013
Clustering of Beijing genotype Mycobacterium tuberculosis isolates from the Mekong delta in Vietnam on the basis of variable number of tandem repeat versus restriction fragment length polymorphism typingMai N T Huyen, Kristin Kremer, Nguyen T N Lan, et al.
Journal of Proteome Research|April 13, 2016
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosisJeroen de Keijzer, Arnout Mulder, Petra E W de Haas, et al.
BMC Infectious Diseases|July 13, 2017
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaSarah Sengstake, Indra L Bergval, Anja R Schuitema, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 1, 2011
Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotypeAnita C Schürch, Kristin Kremer, Robin M Warren, et al.
Journal of Clinical Microbiology|November 1, 2002
False-positive mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequencesAnnette S de Boer, Barbara Blommerde, Petra E W de Haas, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 19, 2019
Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis casesRana Jajou, Thomas A Kohl, Timothy Walker, et al.
Tuberculosis (Edinburgh, Scotland)|November 27, 2014
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T Ten Kate, Dick van Soolingen, et al.
Pageof 28

Showing results (161-170 of 273) with videos related to

Sort By:
Pageof 28
Antimicrobial Agents and Chemotherapy|May 22, 2013
Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomesMai N T Huyen, Frank G J Cobelens, Tran N Buu, et al.
Journal of Clinical Microbiology|March 7, 2006
Isolation of the genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year periodKathleen L Horan, Robert Freeman, Kris Weigel, et al.
Veterinary Immunology and Immunopathology|June 9, 2004
TB diagnosis in non-human primates: comparison of two interferon-gamma assays and the skin test for identification of Mycobacterium tuberculosis infectionRichard A W Vervenne, Stephen L Jones, Dick van Soolingen, et al.
BMC Infectious Diseases|February 5, 2013
Clustering of Beijing genotype Mycobacterium tuberculosis isolates from the Mekong delta in Vietnam on the basis of variable number of tandem repeat versus restriction fragment length polymorphism typingMai N T Huyen, Kristin Kremer, Nguyen T N Lan, et al.
Journal of Proteome Research|April 13, 2016
Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosisJeroen de Keijzer, Arnout Mulder, Petra E W de Haas, et al.
BMC Infectious Diseases|July 13, 2017
Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in GeorgiaSarah Sengstake, Indra L Bergval, Anja R Schuitema, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 1, 2011
Mutations in the regulatory network underlie the recent clonal expansion of a dominant subclone of the Mycobacterium tuberculosis Beijing genotypeAnita C Schürch, Kristin Kremer, Robin M Warren, et al.
Journal of Clinical Microbiology|November 1, 2002
False-positive mycobacterium tuberculosis cultures in 44 laboratories in The Netherlands (1993 to 2000): incidence, risk factors, and consequencesAnnette S de Boer, Barbara Blommerde, Petra E W de Haas, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 19, 2019
Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis casesRana Jajou, Thomas A Kohl, Timothy Walker, et al.
Tuberculosis (Edinburgh, Scotland)|November 27, 2014
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacyGerjo J de Knegt, Marian T Ten Kate, Dick van Soolingen, et al.
Pageof 28